Roche Mergers & Acquisitions

Roche M&A Summary

Roche has acquired 47 companies, including 8 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 2 assets.

Roche’s largest acquisition to date was in 2009, when it acquired Genentech for $46.8B. Roche has acquired in 10 different US states, and 9 countries. The Company’s most targeted sectors include life science (71%) and medical products (12%).

M&A Summary

  • M&A Total Activity46
    • M&A Buy Activity44
    • M&A Sell Activity2
  • Total Sectors Invested 8
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 11

Roche

Roche Holding AG

Konzern-Hauptsitz Grenzacherstrasse124,
Basel, 4070
Switzerland,
+41 61 688 11 11
www.roche.com

All (46) Buy (44) Sell (2)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-09-17 89bio · Life Science
San Francisco, California · www.89bio.com

89bio operates as a biopharmaceutical company that focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. 89bio was formed in 2018 and is based in San Francisco, California.

Advisors: Centerview Partners , Gibson, Dunn & Crutcher , Moelis & Co.
2,400 Add-on Acquisition

Roche
Advisors: Citi , Sidley

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.